ISPUB.com / IJEM/6/2/3492
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Emergency Medicine
  • Volume 6
  • Number 2

Original Article

Spontaneous Subdural Hematoma Secondary to Warfarin Toxicity in a Case with Deep Vein Thrombosis and Pulmonary Embolism

Y Roka, G Paudel, B K.C, S Munakomi

Keywords

deep vein thrombosis, pulmonary embolism, subdural hematoma, warfarin

Citation

Y Roka, G Paudel, B K.C, S Munakomi. Spontaneous Subdural Hematoma Secondary to Warfarin Toxicity in a Case with Deep Vein Thrombosis and Pulmonary Embolism. The Internet Journal of Emergency Medicine. 2009 Volume 6 Number 2.

Abstract

Warfarin is one of the common drugs used in the treatment of deep vein thrombosis, pulmonary embolism and atrial fibrillation with stroke. Warfarin-associated intracerebral hemorrhage (ICH) has become common in the last decades contributing to 19% of intracerebral bleeds. We report a case with deep vein thrombosis that developed acute onset neurosurgical deterioration secondary to left subdural hematoma. Burr hole evacuation was done with correction of the coagulopathy.

 

Introduction

Warfarin is one of the common drugs used in the treatment of deep vein thrombosis, pulmonary embolism, mechanical heart valves and chronic atrial fibrillation with stroke. The incidence of intracerebral hematoma (ICH) secondary to warfarin use has been increasing over the last decade.1

Case Report

A 28-year old female presented to the emergency with history of loss of consciousness (LOC) for one day. There was no history of trauma, fever, headache, seizure or vomiting preceding the LOC. Her pupils were unequal with the left dilated and nonreacting to light. The Glasgow Coma Score (GCS) was 9. One month back she had presented with left leg swelling and the Venous Doppler study had shown left sided deep vein thrombosis involving the common iliac, common femoral and superficial veins with cellulitis (Figure-1).

Figure 1
Fig.1. Venous Doppler showing absent flow in the common iliac, femoral and superficial veins of the left leg

Computed tomogram (CT) of the thorax had also shown pulmonary embolism during the initial presentation (Figure-2).There were no features of coagulopathy, intrabdominal abnormality and drug intake during initial workup. She was started on warfarin 6 mg once daily dose and discharged with follow-up at two weekly intervals with International Normalised Rate (INR) reports.

Figure 2
Fig.2. CT thorax showing a wedge shaped peripheral lung opacity suggestive of pulmonary embolism.

Urgent CT head was done which showed a large acute on chronic subdural hematoma on the left side with gross midline shift (Figure-3).

Figure 3
Fig.3. CT heads showing a large left subdural hematoma with gross midline shift and compression of ipsilateral ventricle.

The Prothrombin time (PT) was 40 with INR of 4. Rest of the blood picture including platelets was normal. In view of the gross midline shift and poor GCS immediate surgery was planned under fresh blood, vitamin K and fresh frozen plasma (FFP) coverage with high risk consent. Single burr hole evacuation of the subdural hematoma with closed drainage was performed. Intraoperatively the blood was under significant pressure and there was no active bleeding present at the end of surgery. Care was taken not to breach the inner membrane of brain cortex. Postoperatively the GCS improved to 12 on the first postoperative day. FFP and vitamin K continued after operation with correction of the PT on the seventh day. She is in follow up with the internal medicine for further management of her DVT and to restart anticoagulants.

Discussion

Warfarin is one of the common drugs used in the treatment of deep vein thrombosis, pulmonary embolism, mechanical heart valves and chronic atrial fibrillation with stroke. It acts by inhibiting the hepatic synthesis of coagulation factors II, VII, IX, X and the anticoagulant proteins C and S which are vitamin K-dependent. The most common adverse effect of warfarin is bleeding in any location, which may be fatal or nonfatal followed by skin necrosis. Warfarin-associated intracerebral hemorrhage (ICH) has become common in the last decades contributing to 19% of intracerebral bleeds.1 The hematomas in this group are also larger than other causes of spontaneous ICH.2 ICH secondary to warfarin present as a neurosurgical emergency with a 30 day mortality of 50% if untreated.3

Reversible of coagulopathy is the first aim, although the specific drug has yet to be defined.3 INR has been universally used to monitor the extent of warfarinisation. Many studies have shown that the previous INR or the INR at presentation has no correlation in predicting the incidence of intracerebral bleed.4,5 In a study by Jeffree et al they found that ICH was more common in the warfarin group and concluded that despite INR monitoring warfarin use was associated with an increased risk of ICH.4

Surgical management of this hematoma depends on their size, location, mass effect and GCS of the patient on presentation. Low GCS and large hematoma have poor prognosis.5 All those with favorable GCS, no mass effect and small hematoma can be initially tried with conservative management.6 Burr hole evacuation under FFP cover is the common neurosurgical procedure performed. In the elderly care needs to be taken to avoid concomitant use of other drugs like aspirin and antiplatelet agents that can increase the chances of coagulopathy.7

Thus all patients on warfarin must be clinically observed for any neurological deterioration to rule out ICH. Repeat INR although not predicting ICH incidence helps to check the level of warfarinisation. Urgent CT with reversible of coagulation with or without surgery can help save life and prevent further morbidity.

References

1. Flaherty ML, Adeoye O, Sekar P, Haverbusch M, Moomaw CJ, Tao H, et al. The challenge of designing a treatment trial for warfarin-associated intracerebral hemorrhage. Stroke 2009 40:1738-42
2. Flaherty ML, Tao H, Haverbusch M, Sekar P, Kleindorfer D, Kissela B, et al. Warfarin use leads to larger intracerebral hematomas. Neurology 2008 71:1084-9
3. Freeman WD, Aguilar MI. Management of warfarin-related intracerebral hemorrhage. Expert Rev Neurother 2008 8:271-90
4. Jeffree RL, Gordon DH, Sivasubramaniam R, Chapman A. Warfarin related intracranial haemorrhage: a case-controlled study of anticoagulation monitoring prior to spontaneous subdural or intracerebral haemorrhage. J Clin Neurosci 2009 16:882-5
5. Zubkov AY, Mandrekar JN, Claassen DO, Manno EM, Wijdicks EF, Rabinstein AA. Predictors of outcome in warfarin-related intracerebral hemorrhage. Arch Neurol 2008 65:1320-5
6. Kinjo T, Mukawa J, Nakata M, Kinjo N. Chronic subdural hematoma secondary to coagulopathy. No Shinkei Geka 1991 19:991-7 [Article in Japanese]
7. McClaskey EM, Michalets EL. Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin: case report and review of the literature. Pharmacotherapy 2007 27:152-60

Author Information

Y.B. Roka, M.S, M.Ch (Neurosurgery), FNNI (Skull Base Surgery), Additional Professor
Department of Surgery, Neurosurgical Unit, B. P. Koirala Institute of Health Sciences

G. Paudel, M.S, Senior Resident Surgery
Department of Surgery, Neurosurgical Unit, B. P. Koirala Institute of Health Sciences

Bidur K.C, MBBS, Surgery Resident
Department of Surgery, Neurosurgical Unit, B. P. Koirala Institute of Health Sciences

S. Munakomi, MBBS, Surgery Resident
Department of Surgery, Neurosurgical Unit, B. P. Koirala Institute of Health Sciences

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy